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Abstract 
Review on Chondroblastoma, with data on clinics, 
and the genes involved. 
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Identity 
Note 
Chondroblastoma is a locally aggressive, rarely 
metastasizing bone tumour typically affecting the 
epiphyses of long bones from individuals with an 
immature skeleton. 
Radiology of Chondroblastoma. 
Phylum 
Bones:Cartilage tumors:Chondroblastoma 
Figures 1, 2 and 3:  Typical radiological findings of a lytic eccentric lesion affecting the epyphysis of the 
humerus (1 RX, 2 NMR and 3 bone scan) 
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Clinics and pathology 
 
Figure 4:  The cellular areas are made up of polygonal cells with scattered multinucleated giants cells 
(Haematoxylin-Eosin stain). 
 Figure 5:  The polygonal cells are positive for S-100 immunostain. 
Figure 6:  The polygonal lesional cells are focally positive for DOG1 
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Epidemiology 
Chondroblastoma is a rare neoplasm accounting for 
less than 1% of all bone tumors. Age of occurrence 
is usually between 10 and 25 years with a male 
predominance. Older age of presentation for skull 
lesions is reported. 
Clinics 
Usual symptom at presentation is mild localized 
pain. Radiologically it occurs more often as an 
eccentric lytic lesion, with sclerotic borders, 
involving epiphyses of the long bones. 
Pathology 
The tumour is composed of cellular and matrix rich 
areas. Cellular areas are made up of so called 
"chondroblasts": round, or polygonal cells, with an 
oval to round nucleus and with well-defined 
eosinophilic cytoplasm. Mainly in non-decalcified 
sections the chondroblasts appear focally delimited 
by a thin calcification rim, so called "chicken wire". 
Matrix rich areas are composed of different types of 
matrix: chondroid, osteoid, fibrous and rarely mature 
hyaline cartilage. Mitoses, always typical, can be 
quite frequent, especially in the cellular areas. 
 
Immunohistochemical stainings show reactivity of 
the neoplastic cells for S-100 DOG1 (focal) and 
Vimentin; although several other antigens are 
reported to be expressed (i.e. Smooth muscle actin 
and Cytokeratin). Multinucleated giant cells, 
especially at the periphery of matrix-rich areas, are 
almost always found. An associated aneurysmal 
bone cyst occurs in about 1/3 of the cases. 
Histological features of chondroblastoma. 
 
Treatment 
Simple curettage is the standard treatment. 
Evolution 
Rate of recurrence is between 14-18% mainly 
occurring within 2 years, and showing a higher 
occurrence rate in case of temporal bone location. 
Rare lung metastases in benign chondroblastomas, 
are documented. However they are not progressive, 
and therefore simple observation is sufficient, if 
necessary followed by simple surgical resection. 
Prognosis 
The prognosis is good. Rare and doubtful malignant 
progression are described, but no universal criteria 
for this event are currently available, and several 
authors consider this as cases of a misdiagnosis. 
Genetics 
Recently a specific driver mutation in the histone 3 
gene H3F3B (K36M), was identified in 
approximately 95% of chondroblastomas. H3F3B 
mutation detection can be used as a diagnostic tool 
for the distinction of chondroblastoma from other 
giant cell-containing tumors. The mutation can be 
detected using a mutation specific antibody for the 
K36M mutation. 
Cytogenetics 
Cytogenetics Morphological 
DNA flow cytometry studies show chondroblastoma 
mainly to be a low proliferative diploid neoplasm, 
however aneuploid near-diploid populations have 
been reported. 
 
Karyotypic results of 7 cases are available in the 
literature. No specific cytogenic abnormalities 
neither specific type of aberrations are reported 
sofar. However some chromosomes seem to be more 
often involved: 3 cases for chromosome 5, 2 for 
chromosome 8, 2 for chromosome 11 and 2 for 
chromosome 17. 
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